Top

Published in:

01-12-2010 | Original Paper

Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma

Authors: Başak Doğu, Nurşen Yüksel, Mustafa Baki Çekmen, Yusuf Çağlar

Published in: International Ophthalmology | Issue 6/2010

Abstract

A prospective, non-randomized, comparative study was carried out to investigate aqueous humor and serum erythropoietin (EPO) levels in patients with pseudoexfoliation syndrome (PXS), pseudoexfoliative glaucoma (PXG), and, as controls, senile cataract without glaucoma. Aqueous humor was aspirated at the beginning of cataract or combined glaucoma–cataract surgery from 24 patients with PXS, 24 patients with PXG, and 24 patients with cataract only. Venous blood samples were obtained from all patients at the same time. Levels of EPO were measured in aqueous humor and venous blood using a sandwich enzyme-linked immunosorbent assay (ELISA) kit. There was no statistically significant difference between the mean aqueous humor EPO concentrations in eyes with PXS (10.70 ± 7.18 mU/ml), PXG (10.18 ± 7.20 mU/ml) and controls (9.75 ± 5.04 mU/ml) (P = 0.732). There was no statistically significant difference between the mean serum EPO concentrations in eyes with PXS (6.32 ± 2.86 mU/ml), PXG (7.06 ± 4.35 mU/ml) and controls (7.30 ± 4.15 mU/ml) (P = 0.672). Contrary to predictions based on the relation with ischemic processes, no difference was revealed between levels of EPO in aqueous humor and serum in patients with PXS and PXG.

Schlötzer-Schrehardt U, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141(5):921–937CrossRefPubMed

Ritch R, Schlötzer-Schrehardt U (2006) Exfoliation syndrome. Surv Ophthalmol 45:265–315CrossRef

Schlötzer-Schrehardt U, Koca MR, Naumann GO, Volkholz H (1992) Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 110:1752–1756PubMed

Schlötzer-Schrehardt U (2009) Molecular pathology of pseudoexfoliation syndrome/glaucoma–new insights from LOXL1 gene associations. Exp Eye Res 88:776–785CrossRefPubMed

Tezel G, Kass MA, Kolker AE, Becker B, Wax MB (1997) Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma 6(2):83–89CrossRefPubMed

Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N (2004) Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 88(4):523–527CrossRefPubMed

Koliakos GG, Konstas AGP, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R (2003) 8-Isoprostaglandin F2A and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 87:353–356CrossRefPubMed

Borazan M, Karalezli A, Kucukerdonmez C, Bayraktar N, Kulaksizoglu S, Akman A, Akova YA (2009) Aqueous humor and plasma levels of vascular endothelial growth factor and nitric oxide in patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma. doi:10.1097/IJG.0b013e3181aae93e

Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF (2009) Antioxidant status in the aqueous humor of patients with glaucoma associated with exfoliation syndrome. Eye 23(8):1691–1697CrossRefPubMed

10.

Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AG (2008) Prooxidant–antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol 246(10):1477–1483CrossRefPubMed

11.

Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449–489PubMed

12.

Tsai JC, Song BJ, Wu L, Forbes M (2007) Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. J Glaucoma 16(6):567–571CrossRefPubMed

13.

Mulcahy L (2001) The erythropoietin receptor. Semin Oncol 28(suppl 8):19–23CrossRefPubMed

14.

Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978–5982CrossRefPubMed

15.

Brines M, Cerami A (2005) Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6:484–494CrossRefPubMed

16.

Ismail AS, Eldine MMS, Zaki AA (2008) Erythropoietin is a potent ischemia induced angiogenic factor in proliferative diabetic retinopathy. Aust J Basic Appl Sci 2:1320–1324

17.

Jonas JB, Neumaier M (2007) Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy. Clin Exp Ophthalmol 35:186–187CrossRef

18.

Cumurcu T, Bulut Y, Demir HD, Yenisehirli G (2007) Aqueous humor erythropoietin levels in patients with primary open-angle glaucoma. J Glaucoma 16(8):645–648CrossRefPubMed

19.

Wang ZY, Shen LJ, Zhao KK, Song ZM, Qu J (2009) Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Ophthalmic Res 42:138–140CrossRefPubMed

20.

Junk A, Mammis A, Savitz S, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99:10659–10664CrossRefPubMed

21.

Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Remé CE (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718–724CrossRefPubMed

22.

Kilic U, Kilic E, Soliz J, Bassetti CI, Gassmann M, Hermann DM (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 19:249–251PubMed

23.

Tsai JC, Wu L, Worgul B, Forbes M, Cao J (2005) Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 30:1025–1031CrossRefPubMed

24.

Weishaupt J, Rohde G, Polking E, Siren AL, Ehrenreich H, Bähr M (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45:1514–1522CrossRefPubMed

25.

The Advanced Glaucoma Intervention Study Investigators (1994) The advanced glaucoma intervention study. 2. Visual field test scoring and reliability. Ophthalmology 101:1445–1455

26.

Koliakos GG, Konstas A, Triantos A, Ritch R (2000) Increased growth factor activity in the aqueous humour of patients with exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 238:491–495CrossRefPubMed

27.

Ho SL, Dogar GF, Wang J, Crean J, Wu QD, Oliver N, Weitz S, Murray A, Cleary PE, O’Brien C (2005) Elevated aqueous humour tissue inhibitor of matrix metallopoteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol 89(2):169–173CrossRefPubMed

28.

Hu DN, Ritch R, Liebmann J, Liu Y, Cheng B, Hu MS (2002) Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes. J Glaucoma 11(5):406–410CrossRefPubMed

29.

Forooghian F, Razavi R, Timms (2007) Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol 91:1406–1410CrossRefPubMed

30.

Brines M, Cerami A (2006) Discovering erythropoietin’s extra-hematopoietic functions: biology and clinical promise. Kidney Int 70:246–250CrossRefPubMed

31.

Siren AL, Knerlich F, Poser W, Gleiter CH, Brück W, Ehrenreich H (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101:271–276

32.

Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687PubMed

33.

Citirik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu (2007) A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye 21:11–15CrossRefPubMed

34.

Linnér E, Popovic V, Gottffries C-G, Jonsson M, Sjögren M, Wallin A (2001) The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer’s type. Acta Ophthalmol Scand 79:283–285CrossRefPubMed

35.

Yüksel N, Anık Y, Altıntaş O, Onur I, Cağlar Y, Demirci A (2006) Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma. Ophthalmologica 220(2):125–130CrossRefPubMed

36.

Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A (2004) Erythropoietin mediates tissue protection through an erythropoietin and common betasubunit heteroreceptor. Proc Natl Acad Sci USA 101:14907–14912CrossRefPubMed

Title: Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma
Authors: Başak Doğu
Nurşen Yüksel
Mustafa Baki Çekmen
Yusuf Çağlar
Publication date: 01-12-2010
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 6/2010
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-010-9391-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2010

Early unilateral macular sensitivity changes in microperimetry in a case of pituitary adenoma

Deep sclerectomy with the Ex-PRESS X-200 implant for the surgical treatment of glaucoma

The distribution of visual field defects per quadrant in standard automated perimetry as compared to frequency doubling technology perimetry

Aspergillus keratitis in vernal shield ulcer—a case report and review

Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2

Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy